PubRank

Alan M Rapoport

Author PubWeight™ 45.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Migraine and obesity: epidemiology, mechanisms, and implications. Headache 2009 2.05
2 The effect of weather on headache. Headache 2004 1.87
3 Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache 2013 1.65
4 Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 2003 1.53
5 The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE). J Headache Pain 2005 1.52
6 New migraine preventive options: an update with pathophysiological considerations. Rev Hosp Clin Fac Med Sao Paulo 2003 1.41
7 Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 2009 1.32
8 Triptans for the management of migraine. Drugs 2010 1.24
9 Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006 1.16
10 Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 2004 1.08
11 Comment on: "Headaches during war: analysis of presentation, treatment, and factors associated with outcome". Cephalalgia 2012 1.07
12 Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol 2002 1.03
13 Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002 1.00
14 Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases. Headache 2004 0.97
15 The association of obesity with episodic and chronic migraine. Headache 2012 0.96
16 Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 2004 0.93
17 Assessment of adverse events associated with triptans--methods of assessment influence the results. Headache 2004 0.91
18 Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning? Headache 2005 0.90
19 Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache 2004 0.89
20 The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 2005 0.89
21 Sumatriptan: a decade of use and experience in the treatment of migraine. Expert Rev Neurother 2004 0.88
22 The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache 2007 0.87
23 Role of antiepileptic drugs as preventive agents for migraine. CNS Drugs 2010 0.86
24 Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 2009 0.86
25 Obesity and chronic daily headache. Curr Pain Headache Rep 2012 0.85
26 Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. J Headache Pain 2009 0.85
27 Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol 2007 0.84
28 New drug delivery options for migraine. Expert Rev Neurother 2011 0.82
29 Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache 2003 0.82
30 Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs 2006 0.82
31 Ten years of rizatriptan: from development to clinical science and future directions. Headache 2009 0.82
32 Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache 2007 0.81
33 High-altitude headache. Curr Pain Headache Rep 2007 0.81
34 Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine. Neuropsychiatr Dis Treat 2012 0.80
35 Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Headache 2014 0.80
36 Update on future headache treatments. Neurol Sci 2013 0.80
37 Intranasal zolmitriptan for the treatment of acute migraine. Headache 2013 0.79
38 New treatments for headache. Neurol Sci 2014 0.79
39 Hemicrania continua: a report of ten new cases. Arq Neuropsiquiatr 2002 0.78
40 The pipeline in headache therapy. CNS Drugs 2013 0.77
41 Prophylactic migraine therapy: emerging treatment options. Curr Pain Headache Rep 2004 0.77
42 Why does vomiting stop a migraine attack? Curr Pain Headache Rep 2013 0.77
43 New and emerging treatments for headache. Expert Rev Neurother 2012 0.76
44 Chronic daily headache in adolescents: an 8-year follow-up study. Neurology 2010 0.76
45 New developments in migraine prophylaxis. Expert Opin Pharmacother 2003 0.75
46 Emerging treatments for the primary headache disorders. Neurol Sci 2015 0.75
47 Acute and preventive pharmacologic treatment of cluster headache. Neurology 2011 0.75
48 The vasodilatory activity of CGRP: a response. Headache 2014 0.75
49 Analgesic use: a predictor of chronic pain in medication overuse headache: the Head-HUNT study. Neurology 2004 0.75
50 Sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Pain Manag 2014 0.75
51 Parsing the migraine attack. Headache 2013 0.75
52 Ethical considerations in cluster headache research. Curr Pain Headache Rep 2002 0.75
53 Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study. Headache 2005 0.75
54 Advances in the pharmacologic treatment of tension-type headache. Curr Pain Headache Rep 2008 0.75
55 Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review. Clin Neuropharmacol 2017 0.75
56 The next two years. Cephalalgia 2013 0.75
57 A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine. Neurol Sci 2013 0.75